📋 Tender Overview
Novel Effect Biomarkers For Metabolic Disruptors: Evidence On Health Impacts To Answer Science And Policy Needs
Safeguarding Health Amidst The Adverse Metabolic Effects Of Edcsendocrine-Disrupting Chemicals (Edcs) Pose A Complex Threat To Human Health By Affecting Crucial Metabolic Pathways In Organs Such As The Liver And Pancreas. This Interference Is Associated With The Increasing Prevalence Of Obesity, Atherosclerosis And Type 2 Diabetes, With Potential Long-Lasting Effects Spanning Generations. Despite These Widespread Impacts, Understanding The Metabolic Effects Of Edcs Remains Elusive And Is Hindered By A Lack Of Mechanistic Data And Predictive Models. To Address This Gap, The Eu-Funded Nemesis Project Brings Together Experts Across Disciplines To Unravel The Details Of Edc-Induced Metabolic Disruption Through Diverse Research Methodologies And Advanced Data Analytics. Nemesis Aims To Enhance Risk Assessment Strategies And Develop Effective Risk Communication Practices To Maximise The Science-To-Policy Impact Of The Project Findings.
Funded Under
Health
Total Cost
€ 7 965 638,75
Eu Contribution
€ 7 881 685,25
Coordinated By
Ita-Suomen Yliopisto
Finland
Start Date
1 January 2024
End Date
31 December 2028
